Table 1 Patient characteristics (n=45)
Characteristic | No. | % |
|---|---|---|
Age (years) | ||
Median | 57 | |
Range | 20–73 | |
Sex | ||
Male | 32 | 71.1 |
Female | 13 | 28.9 |
ECOG performance status | ||
0 | 7 | 15.6 |
1 | 35 | 77.8 |
2 | 3 | 6.7 |
Extent of disease | ||
Relapsed | 10 | 22.2 |
Initially metastatic | 33 | 73.3 |
Initially locally advanced | 2 | 4.4 |
Prior adjuvant chemotherapy | ||
Yes | 9 | 20 |
5-FU+doxorubicin+mitomycin-C | −3 | |
5-FU or doxifluridine+cisplatin | −5 | |
Doxifluridine+mitomycin-C | −1 | |
No | 36 | 80 |
Metastatic sites | ||
Abdominal lymph node | 33 | 73.3 |
Liver | 20 | 44.4 |
Peritoneum | 12 | 26.7 |
Lung | 7 | 15.6 |
Cervical lymph node | 7 | 15.6 |
Ovary | 3 | 6.7 |
No. of metastases | ||
1 | 19 | 42.2 |
2 | 15 | 33.3 |
⩾3 | 11 | 24.5 |
